Chris Henderson
About Chris Henderson
Title and Current Role
Chris Henderson currently serves as the Chief Scientific Officer. His role involves overseeing scientific research and development, guiding innovation, and ensuring the organization's scientific endeavors align with its strategic goals.
Educational Background
Chris Henderson holds a Ph.D. from the University of Cambridge. Following his doctoral studies, he was a postdoctoral fellow at the Pasteur Institute. These institutions are renowned for their rigorous academic programs and high-impact research, providing Chris with a solid foundation in scientific research and development.
Professional Experience at Biogen
Chris previously served as the Senior Vice President and Head of Research at Biogen. In this role, he led research initiatives, managed research teams, and contributed to the company's strategic planning. His leadership at Biogen helped advance the organization's research capabilities and scientific output.
Leadership in Research Initiatives
Chris co-founded the Center for Motor Neuron Biology and Disease, reflecting his commitment to advancing the understanding of neurodegenerative diseases. Additionally, he was the Director of the Columbia Stem Cell Initiative at Columbia University, where he spearheaded stem cell research initiatives and collaborations.
Contributor to Scientific Community
As an accomplished researcher, Chris has authored over 90 scientific publications. His work has been featured in top-tier scientific journals. He has also served as an editor and reviewer, contributing to the peer review process and helping to maintain the quality and integrity of scientific literature.
Role at Target ALS Foundation
Chris serves as the Chief Advisor of the Target ALS Foundation. In this capacity, he offers strategic guidance on research projects aimed at understanding and combating ALS (Amyotrophic Lateral Sclerosis). His expertise supports the foundation's mission to accelerate ALS research and therapeutic development.